cancer, Targeting therapy, theranosticsEstablishment of 89Zr labeled small sized antibody variants for cancer diagnosis. A study on theranostics technology for cancer using a specific antibody variant and 89Zr labeled DDS systems. Targeting therapy for cancer 'theranostics)2014.09Lipid metablismTrial for profiling of lipid metabolites (oxidized lipids) by using LC-MS/MS. Lipidome (metabolome) analysis2014.04oxidized LDL,foam cell formation,atherosclerosisStudy on atherogenesis1996.04Development and Clinical Application of OXLDL detection system1996.04Antiphospholipid Antibodies,Anticardiolipin AntibodiesStudy on Antiphospholipid Antibodies1988.11α-FetoproteinImmunological and Biochemical Study on α-Fetoprotein1995.112000.10 

Photograph

Name

MATSUURA Eiji

Affiliation

Neutron Medical Research Center

Sex

male

Research areas, keyword

Biochemistry, Immunology, Clinical chemistry, Tumor biology, Molecular imaging

Research Subject 【 display / non-display

  • Subject:Targeting therapy for cancer 'theranostics)

    Object:Establishment of 89Zr labeled small sized antibody variants for cancer diagnosis. A study on theranostics technology for cancer using a specific antibody variant and 89Zr labeled DDS systems.

  • Subject:Lipidome (metabolome) analysis

  • Subject:Study on atherogenesis

 
 

Research Achievement (Published Thesis) 【 display / non-display

  • Subject:Mutants of β2-glycoprotein I: Their features and potent applications.

    Language:English

    Kind of Publishing:Academic Journal

    Journal name:Best Pract Res Clin Rheumatol , vol.32 (4) (p.572 - 590)

    Publish date:2019.02

    Author:Shen L, Azmi NU, Tan XW, Yasuda S, Wahyuningsih AT, Inagaki J, Kobayashi K, Ando E, Sasaki T, Matsuura E

    Co-writerThe multiple authorship

    DOI:10.1016/j.berh.2019.01.007.

  • Subject:Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome

    Language:English

    Kind of Publishing:Academic Journal

    Journal name:Auto Immun Highlights , vol.9 (1) (p.2 - )

    Publish date:2018.02

    Author:Ames PRJ, Lopez LL, Merashli M, Matsuura E

    Co-writerThe simple work

    DOI:10.1007/s13317-018-0103-3

  • Subject:Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice

    Language:English

    Kind of Publishing:Academic Journal

    Journal name:Molecular Therapy - Methods and Clinical Development , vol.6 (p.31 - 39)

    Publish date:2017.09

    Author:Haruki Watanabe*,Katsue S. Watanabe ,Keyue Liu,Sumie Hiramatsu,Sonia Zeggar ,Eri Katsuyama,Noriko Tatebe ,Akiya Akahoshi,Fumiaki Takenaka*,Takahisa Hanada,Masaru Akehi*,Takanori Sasaki*,Ken ei Sada *,Eiji Matsuura*,Masahiro Nishibori*,Jun Wada*

    Co-writerThe multiple authorship

    DOI:10.1016/j.omtm.2017.05.006

  • Subject:The lipid moiety 7-ketocholesteryl-9-carboxynonanoate mediates binding interaction of oxLDL to LOX-1 and upregulates ABCA1 expression through PPARγ

    Language:English

    Kind of Publishing:Academic Journal

    Journal name:Life Sciences, Life sciences. Pt. 2: Biochemistry, general and molecular biology , vol.177 (p.27 - 40)

    Publish date:2017.05

    Author:Jingda Li,Zhilong Xiu,Renjun Wang,Chengjie Yu,Yan Chi,Jianzhong Qin,Changzhen Fu,Eiji Matsuura*,Qingping Liu

    Co-writerThe multiple authorship

    DOI:10.1016/j.lfs.2017.03.024

  • Subject:In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β2-glycoprotein I complexes into atherosclerotic plaques of WHHL rabbits: Implication for clinical PET imaging. (Original)

    Language:English

    Kind of Publishing:Academic Journal

    Journal name:Autoimmun Rev , vol.16 (2) (p.159 - 167)

    Publish date:2017.02

    Author:Sasaki T, Kobayashi K, Kita S, Kojima K, Hirano H, Shen L, Takenaka F, Kumon H, Matsuura E.

    Co-writerThe multiple authorship

    DOI:doi: 10.1016/j.autrev.2016.12.007

display all >>